IL17A and neoplasm: However, MC activation by nociceptor-derived AM has not been demonstrated in vivo. Interestingly, MCs are a prominent component of solid tumors and, in the tumor microenvironment, can be readily activated by tumor cell-derived AM, resulting in IL-17A release and enhanced tumor growth (306).